This study is currently not recruiting participants.

Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis in High Risk Patients: Searching for the Optimal Dose. A Prospective Randomized Trial

Study on the Effectiveness of an Investigational Medication to Reduce Pancreatitis Risk During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to determine if a higher dose of a suppository of a drug called indomethacin at the time of ERCP can further decrease the risk of pancreatitis related to the procedure.

Detailed description of study

The purpose of this study is to determine if a higher dose of a suppository of a drug called indomethacin at the time of ERCP can further decrease the risk of pancreatitis related to the procedure.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pancreatitis
  • Age: 18 years - 100 years
  • Gender: All

This study investigates the use of an investigational medication in the form of a suppository to see if a higher dose can reduce the risk of pancreatitis, which is inflammation of the pancreas, after a procedure called ERCP. ERCP stands for Endoscopic Retrograde Cholangiopancreatography, a procedure used to examine the pancreatic and bile ducts.

Participants in this study will receive either a higher dose of the investigational medication or a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine. The study will assess the effectiveness of the higher dose in preventing pancreatitis after the ERCP procedure.

  • Who can participate: The eligibility criteria for this study have not been specified.
  • Study details: Participants will receive either a higher dose of the investigational medication or a placebo.
Updated on 19 Feb 2024. Study ID: 1304011318

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team